These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18995886)

  • 1. Circulating procoagulant microparticles in patients with venous thromboembolism.
    Ay C; Freyssinet JM; Sailer T; Vormittag R; Pabinger I
    Thromb Res; 2009 Mar; 123(5):724-6. PubMed ID: 18995886
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating procoagulant microparticles in cancer patients.
    Thaler J; Ay C; Weinstabl H; Dunkler D; Simanek R; Vormittag R; Freyssinet JM; Zielinski C; Pabinger I
    Ann Hematol; 2011 Apr; 90(4):447-53. PubMed ID: 20981426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of circulating procoagulant microparticles in patients with beta-thalassemia intermedia.
    Habib A; Kunzelmann C; Shamseddeen W; Zobairi F; Freyssinet JM; Taher A
    Haematologica; 2008 Jun; 93(6):941-2. PubMed ID: 18460647
    [No Abstract]   [Full Text] [Related]  

  • 4. Are endothelial microparticles potential markers of vascular dysfunction in the antiphospholipid syndrome?
    Pericleous C; Giles I; Rahman A
    Lupus; 2009 Jul; 18(8):671-5. PubMed ID: 19502261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombotic state in glioblastoma multiforme: an evaluation of the procoagulant activity of circulating microparticles.
    Sartori MT; Della Puppa A; Ballin A; Saggiorato G; Bernardi D; Padoan A; Scienza R; d'Avella D; Cella G
    J Neurooncol; 2011 Aug; 104(1):225-31. PubMed ID: 21104297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein Z g-42a variant and the risk of pregnancy-related venous thromboembolism in a cohort of Italian patients.
    Grandone E; Favuzzi G; De Stefano V; Chinni E; Rossi E; Cappucci F; Margaglione M
    Thromb Res; 2009 Apr; 123(6):848-50. PubMed ID: 19185907
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microparticles in pregnant patients with primary anti-phospholipid syndrome: an exploratory study.
    Campello E; Radu CM; Tonello M; Kuzenko A; Bulato C; Hoxha A; Mattia E; Spiezia L; Ruffatti A; Simioni P
    Scand J Rheumatol; 2018 Nov; 47(6):501-504. PubMed ID: 29308695
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of thermal trauma on pro- and anticoagulant activity of erythrocyte-derived microvesicles.
    Levin G; Sukhareva E
    Burns; 2016 Nov; 42(7):1528-1533. PubMed ID: 27268106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism in patients receiving multimodality therapy for thoracic malignancies.
    Patel A; Anraku M; Darling GE; Shepherd FA; Pierre AF; Waddell TK; Keshavjee S; de Perrot M
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):843-8. PubMed ID: 19660355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism: risk factors for recurrence.
    Zhu T; Martinez I; Emmerich J
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microparticles: new light shed on the understanding of venous thromboembolism.
    Zhou L; Qi XL; Xu MX; Mao Y; Liu ML; Song HM
    Acta Pharmacol Sin; 2014 Sep; 35(9):1103-10. PubMed ID: 25152025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma annexin A5 and microparticle phosphatidylserine levels are elevated in sickle cell disease and increase further during painful crisis.
    van Tits LJ; van Heerde WL; Landburg PP; Boderie MJ; Muskiet FA; Jacobs N; Duits AJ; Schnog JB
    Biochem Biophys Res Commun; 2009 Dec; 390(1):161-4. PubMed ID: 19799864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-dimer before chemotherapy might predict venous thromboembolism.
    Arpaia G; Carpenedo M; Verga M; Mastrogiacomo O; Fagnani D; Lanfredini M; Milani M; Cimminiello C
    Blood Coagul Fibrinolysis; 2009 Apr; 20(3):170-5. PubMed ID: 19276795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of phosphatidylserine-dependent antiprothrombin antibody on thrombin generation.
    Sakai Y; Atsumi T; Ieko M; Amengual O; Furukawa S; Furusaki A; Bohgaki M; Kataoka H; Horita T; Yasuda S; Koike T
    Arthritis Rheum; 2009 Aug; 60(8):2457-67. PubMed ID: 19644870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MP's and VTE's: Fact or fiction.
    Owens AP; Mackman N
    Thromb Res; 2011 Dec; 128(6):505-6. PubMed ID: 21945232
    [No Abstract]   [Full Text] [Related]  

  • 17. Of matters great and small.
    Versteeg HH; Rodger M
    Thromb Res; 2017 Feb; 150():101. PubMed ID: 28137540
    [No Abstract]   [Full Text] [Related]  

  • 18. Biomarkers and venous thromboembolism.
    Pabinger I; Ay C
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):332-6. PubMed ID: 19228607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic efficacy of leukocytapheresis for procoagulant microparticles during hemophagocytic syndrome.
    Asai T; Nomura S; Ishii K; Ichikawa K; Umei N; Matsunami K; Matsuo Y; Kitazawa Y
    Pathophysiol Haemost Thromb; 2008; 36(2):98-101. PubMed ID: 19127090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberine-induced decline in circulating CD31+/CD42- microparticles is associated with improvement of endothelial function in humans.
    Wang JM; Yang Z; Xu MG; Chen L; Wang Y; Su C; Tao J
    Eur J Pharmacol; 2009 Jul; 614(1-3):77-83. PubMed ID: 19401197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.